{"id":53584,"date":"2023-02-02T17:02:32","date_gmt":"2023-02-02T16:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/"},"modified":"2023-02-02T17:02:32","modified_gmt":"2023-02-02T16:02:32","slug":"mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/","title":{"rendered":"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series"},"content":{"rendered":"
\n

TOKYO–(BUSINESS WIRE)–MIRAILAB BIOSCIENCE Inc. (HQ: Tokyo, Japan; CEO: Megumi Tanaka) is proud to announce our new product category: the health mailing kit series. You can use these kits from the comfort of your home, without visiting any clinic. Just swab your mouth, send us the sample and receive an analysis report informing you of your present and future health. The results of these analyses will be very useful to help you stay in good shape.\n<\/p>\n

<\/a><\/p>\n

\nWe were the first company in the world to market NMN supplements, and the pioneers of human clinical studies (\u201cAssessment of Effects of Long-term Administration of Nicotinamide Mononucleotide (NMN)\u201d, with Hiroshima University, the Graduate School of Biomedical & Health Sciences.) Our NMN is also used in research funded by the U.S. Department of Defense carried out at Washington University (“Effect of NMN Supplementation on Organ System Biology”), and joint research we are conducting in collaboration with Tokyo University (“Randomized, Double-blind, Placebo-controlled Parallel-group Comparative Study to Evaluate the Effect of High-dose Nicotinamide Mononucleotide (NMN) on Aging”).\n<\/p>\n

\nWhile researching and developing NMN products, we have also created a service that allows you to visualize your degree of aging by postal mail. At present, our mailing kit series consists of \u201cMitochondria Quantitation Kit- Energy Check<\/i>\u201d<\/i> and \u201cAI Disease Prediction Kit- Risk Check<\/i>.\u201d\n<\/p>\n

\nWith the Mitochondria Quantitation Kit- Energy Check<\/i> you can find out from your own home the amount of mitochondria in you (these little elongate structures are essential for many of the functions in your cells.) Thanks to this test you can see how many mitochondria your body has, and by carrying out an analysis that applies the unique database we have obtained from our clinical research, we can determine your health status and your degree of aging.\n<\/p>\n

\nLatest research has shown that the speed of aging, which is different from person to person, is related to the reduction of mitochondria in our cells(1)<\/sup>. People with a high number of mitochondria are less prone to suffer from cognitive or physical decline or have obesity with visceral fat, and have a low risk of dying(2)<\/sup>.\n<\/p>\n

\nMitochondria are organelles that exist in every cell of your body in a number ranging from 10 to 100 and play a fundamental role in the functions that keep you alive. Mitochondria chemically binds the nutrients you absorb from your diet (like sugars or fats) and the oxygen you breathe to extract the energy these nutrients contain.\n<\/p>\n

\nThe administration of nicotinamide mononucleotide (NMN) is being researched as a method to restore the number of mitochondria that we lose as we get old. Nicotinamide adenine dinucleotide (NAD) is generated in our cells from NMN, so we can expect to increase the number of mitochondria if we activate the factors related to their production.\n<\/p>\n

\nAI Disease Prediction Kit- Risk Check<\/i> is a service that uses AI to predict the risk of having the following 13 diseases and conditions in the future: diabetes, cardiac disease, dementia, Alzheimer\u2019s, stomach cancer, colon cancer, liver cancer, lung cancer, breast cancer, prostate cancer, stroke, hypertension, and dyslipidemia. For this analysis, we need your answers to the simple form that we send you (just circle the right choice to let us know your history of illnesses and your smoking, drinking, and other lifestyle habits, as well as those of your closest relatives) and the results of your last three annual health checkups.\n<\/p>\n

\nThe disease prediction report displays graphically the predicted risk of developing each disease or condition and lists the health checkup items that affected the AI-calculated risk prediction according to their impact, displaying for each checkup item: (a) current status, (b) deviation from the reference value, and (c) average value in individuals of the same age\/gender.\n<\/p>\n

\nWhile we are preparing for the launch of our mailing analysis kits on a global scale, at present they are available only in Japan. Soon, we plan to add new products to our lineup of mailing kits and expand to new markets.\n<\/p>\n

\nYou can buy our NMN products from the links below:\n<\/p>\n

\nWorld Shopping BIZ
\n
<\/b>https:\/\/worldshopping.force.com\/help\/s\/?language=en_US<\/a>\n<\/p>\n

\nAmazon
\n
<\/b>https:\/\/www.amazon.com\/stores\/page\/0701DACE-F0AC-44CD-BD6B-61E88CF7CBF0?ingress=2&visitId=d1fc9026-774d-40c8-af3d-850115b1d14a&ref_=ast_bln<\/a>\n<\/p>\n

\nAs a leading NMN company, at Mirailab Bioscience we continue to work towards the global realization of productive aging based on scientific evidence and to contribute to the improvement of society\u2019s quality of life.\n<\/p>\n

\nFootnotes:
\n
(1) Short KR, et al. Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5618-23. doi: 10.1073\/pnas.0501559102. Epub 2005 Mar 30. PMID: 15800038
\n
(2) Fazzini F, et al. J Intern Med. 2021 Jul;290(1):190-202. doi: 10.1111\/joim.13242. Epub 2021 Feb 20. PMID: 33453124\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInquiries:
\n
MIRAILAB BIOSCIENCE Inc.
\n
Agustin Martin
\n
+81-3-5403-6393
\n
info@mirailab-bio.com<\/a>
https:\/\/www.mirailab-bio.com\/en\/contact\/<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOKYO–(BUSINESS WIRE)–MIRAILAB BIOSCIENCE Inc. (HQ: Tokyo, Japan; CEO: Megumi Tanaka) is proud to announce our new product category: the health mailing kit series. You can use these kits from the comfort of your home, without visiting any clinic. Just swab your mouth, send us the sample and receive an analysis report informing you of your … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53584","6":"format-standard","7":"category-industry"},"yoast_head":"\nMIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOKYO–(BUSINESS WIRE)–MIRAILAB BIOSCIENCE Inc. (HQ: Tokyo, Japan; CEO: Megumi Tanaka) is proud to announce our new product category: the health mailing kit series. You can use these kits from the comfort of your home, without visiting any clinic. Just swab your mouth, send us the sample and receive an analysis report informing you of your ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T16:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230130005800\/en\/1702322\/21\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series\",\"datePublished\":\"2023-02-02T16:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/\"},\"wordCount\":814,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005800\\\/en\\\/1702322\\\/21\\\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/\",\"name\":\"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005800\\\/en\\\/1702322\\\/21\\\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg\",\"datePublished\":\"2023-02-02T16:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005800\\\/en\\\/1702322\\\/21\\\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005800\\\/en\\\/1702322\\\/21\\\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/","og_locale":"en_US","og_type":"article","og_title":"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series - Pharma Trend","og_description":"TOKYO–(BUSINESS WIRE)–MIRAILAB BIOSCIENCE Inc. (HQ: Tokyo, Japan; CEO: Megumi Tanaka) is proud to announce our new product category: the health mailing kit series. You can use these kits from the comfort of your home, without visiting any clinic. Just swab your mouth, send us the sample and receive an analysis report informing you of your ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-02T16:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230130005800\/en\/1702322\/21\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series","datePublished":"2023-02-02T16:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/"},"wordCount":814,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005800\/en\/1702322\/21\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/","url":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/","name":"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005800\/en\/1702322\/21\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg","datePublished":"2023-02-02T16:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230130005800\/en\/1702322\/21\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230130005800\/en\/1702322\/21\/53294274_MIRAILAB_BIOSCIENCE_clear_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mirailab-bioscience-inc-the-leading-company-in-nmn-supplements-announces-health-mailing-kit-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53584"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53584\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}